Comprehensive Myeloma Protein Panel – Advance

What is CMPP - Comprehensive Myeloma Protein Panel– Advance test?

The CMPP – Comprehensive Myeloma Protein Panel – Advance is an extensive blood test panel designed to detect, evaluate, and monitor multiple myeloma and related plasma cell disorders. This advanced panel is ideal for diagnosis, risk assessment, and monitoring response to therapy in multiple myeloma patients.

Parameter Covered: SERUM PROTEIN ELECTROPHORESIS (SPE), IMMUNOFIXATION ELECTROPHORESIS (IFE), IMMUNOGLOBULIN (IGG, IGM, IGA), SERUM FREE LIGHT CHAIN KAPPA & LAMBDA RATIO, CALCIUM, BLOOD UREA NITROGEN, CREATININE, CBC

Why consider CMPP - Comprehensive Myeloma Protein Panel– Advance test?

Comprehensive Myeloma Protein Panel – Advance test is recommended to:

• Detect and diagnose multiple myeloma or related plasma cell disorders.

• Monitor disease progression and response to therapy.

• Evaluate organ function (kidney and bone health) affected by myeloma.

• Detect complications such as anemia or hypercalcemia.

• Provide a comprehensive assessment for personalized treatment planning.

Who should get tested for CMPP - Comprehensive Myeloma Protein Panel– Advance test in Kochi?

Comprehensive Myeloma Protein Panel – Advance test is indicated for:

• Patients with suspected multiple myeloma or plasma cell disorders.

• Individuals undergoing treatment for myeloma for disease monitoring.

• Patients with abnormal protein levels, anemia, kidney issues, or bone lesions.

• Those needing a comprehensive baseline evaluation before starting therapy.

• Clinicians seeking a detailed and holistic view of disease and organ function in myeloma patients.

More Information on Comprehensive Myeloma Protein Panel – Advance in Kochi

OTHER NAMES:

Multiple myeloma (MM) is a cancer of plasma cells, which are a type of white blood cell that produce antibodies (immunoglobulins) to help fight infections. In multiple myeloma, abnormal plasma cells grow uncontrollably in the bone marrow and produce large amounts of monoclonal (M) protein, which doesn’t function like normal antibodies. This leads to organ damage and interference with the production of normal blood cells.